This repository accompanies the study “Antigenic and structural diversity of the intrinsically disordered malaria vaccine candidates CSP and MSP2” (Braeken et al., 2025). It makes the exact amino-acid ...
Sri Lanka after eliminating malaria in 2012, is in the prevention of re-establishment (POR) phase. Being a tropical country with high malariogenic potential, maintaining vigilance is important. All ...
The merozoite surface protein 2 (MSP2) is a leading asexual-stage malaria vaccine candidate that has already proven to have an effect in phase I/IIb vaccine trials, where it was tested in combination ...
The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending on the drugs' residence time) following initiation of treatment in order to capture late failures. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback